10-47322729-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_016204.4(GDF2):c.61C>T(p.Gln21*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000689 in 1,451,602 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_016204.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.89e-7 AC: 1AN: 1451602Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 720284
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Telangiectasia, hereditary hemorrhagic, type 5 Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gln21*) in the GDF2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GDF2 are known to be pathogenic (PMID: 26801773, 31661308, 31727138). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with GDF2-related conditions. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.